Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
PL02 - Plenary 2: Multidisciplinary Approach to the Oligo Paradigm (Live Streamed Session)
- 08:30 - 10:00
- 8/07/2022
- Location: Hall C1
- IASLC CME Accredited
- Type: Plenary
- Track: N/A
- Moderators:Francoise Mornex, Hisao Asamura
-
+
PL02.05 - Definitions of Oligometastatic Disease - Biological Bases and Specificities
Presenter: John Heymach- Abstract
Loading...
-
+
MA01 - Molecular Subtypes and Prognostic Factors for SCLC and Neuroendocrine Tumors
- 10:45 - 11:45
- 8/07/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
- Moderators:Fabio Pagni, Ferdinandos Skoulidis
-
+
MA01.03 - Exploiting DNA Methylation for Classification of SCLC Subtypes from Liquid Biopsies Using a Robust Machine Learning Approach
10:47 - 10:52 | Presenter: Simon Heeke
- Abstract
Loading...
-
+
IS12 - Industry Symposium Sponsored by AstraZeneca: Expanding Horizons in Metastatic NSCLC: Unmet Need and Future Directions
- 13:15 - 14:15
- 8/07/2022
- Location: Hall C7
- Not for CME Credit
- Type: Industry Symposium
- Track: N/A
-
+
Session Moderator
13:15 - 13:15 | Presenter: John Heymach
- Abstract
Loading... -
+
IS12.01 - Welcome and Introduction
13:15 - 13:20 | Presenter: John Heymach
- Abstract
Loading...
-
+
EP02.04 - Early Stage Non-small Cell Lung Cancer - Systemic Therapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Early Stage Non-small Cell Lung Cancer - Systemic Therapy
-
+
EP02.04-005 - Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ NSCLC
Presenter: JAY M LEE- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-049 - A Phase I Trial of the HER2 Exon 20 Inhibitor, BI 1810631, In Patients With Advanced Solid Tumors With HER2 Aberrations
Presenter: Frans Opdam- Abstract
Loading... -
+
EP08.02-163 - Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer
Presenter: Xiuning Le- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- 14:30 - 15:30
- 8/09/2022
- Location: Hall C7
- Not for CME Credit
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Moderators:Pilar Garrido, António Araújo
-
+
OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy
14:52 - 15:02 | Presenter: Benjamin Besse
- Abstract
Loading...
